Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) shares dropped 0.4% during trading on Wednesday . The company traded as low as $3.52 and last traded at $3.54. 7,479 shares traded hands during mid-day trading, a decline of 44% from the average daily volume of 13,389 shares. The stock had previously closed at $3.5550.
Medexus Pharmaceuticals Stock Performance
The company’s 50-day moving average is $3.26 and its 200 day moving average is $2.74.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
